Shandong Xinhua Pharmaceutical Co. Ltd. provided earnings guidance for the year ended December 31, 2013. The board of directors of the company announced that the Group is expected to record an increase in the net profit attributable to the Shareholders for the period from 1 January 2013 to 31 December 2013, as compared to the corresponding period in 2012.

The company expected profit of approximately RMB 30,760,000 to ­RMB 40,220,000 (representing an increase of 30%-70% as compared with that of the same period last year) and basic earnings per share of approximately RMB 0.07 to RMB 0.09.